Monitor future Form 4 filings for any exercise or disposition activity. This Form 3 is administrative and does not signal changes in insider sentiment or company fundamentals.
Price Chart
Executive Summary
Thomas Folinsbee, an officer of CASI Pharmaceuticals, filed a Form 3 disclosing ownership of stock options. The filing is routine and reflects initial reporting of existing equity awards with no new transactions or changes in beneficial ownership structure.
Key Facts
- Form 3 filed by Thomas Folinsbee, an officer of CASI Pharmaceuticals, on April 23, 2026, with a reporting date of March 18, 2026.
- Discloses ownership of fully vested stock options to purchase ordinary shares, with expiration dates ranging from 2033 to 2035.
- No shares are directly owned; only options to buy shares are reported.
- This is an initial ownership filing, not a transaction report, and does not indicate new insider activity.
Financial Impact
No immediate financial impact — options are already vested and no new grants or exercises are reported.
Risk Factors
- Potential for future dilution if options are exercised, though not imminent.
- Limited transparency due to lack of specific share count or exercise price details in the filing.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 3 Filing (Primary) | 0001104659-26-047080 |
| Document: 0001104659-26-047080-index.html | 0001104659-26-047080 |
| Document: 0001104659-26-047080.txt | 0001104659-26-047080 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 2, 2026 7w ago | 6-K | $0.1400 | awaiting T+60 | — | $0.1000 (−28.57%) |
Aug 14, 2026 10w ago | 6-K | $0.1500 | awaiting T+60 | — | $0.1000 (+33.33%) |
Jul 15, 2026 14w ago | 6-K | $0.1400 $0.1100 | ▼ −21.43% | ▼ −24.22% | $0.1000 (−28.57%) |
Jun 29, 2026 17w ago | 6-K | $0.1200 $0.1300 | ▲ +8.33% | ▲ +5.29% | $0.1000 (−16.67%) |
Jun 2, 2026 21w ago | 6-K | $0.1100 $0.1300 | ▲ +18.18% | ▲ +17.06% | $0.1000 (−9.09%) |
Apr 23, 2026 26w ago | 3 | $0.1300 $0.1700 | ▲ +30.77% | ▲ +25.75% | $0.1000 (−23.08%) |
Apr 20, 2026 27w ago | 6-K | $0.1700 $0.1344 | ▼ −20.94% | ▼ −27.84% | $0.1000 (−41.18%) |
Apr 20, 2026 27w ago | 6-K | $0.1700 $0.1250 | ▲ +26.47% | ▲ +33.25% | $0.1000 (+41.18%) |
Apr 15, 2026 27w ago | 6-K | $0.1500 $0.1451 | ▼ −3.27% | ▼ −11.40% | $0.1000 (−33.33%) |
Apr 3, 2026 29w ago | 3 | $0.1400 $0.2400 | ▲ +71.43% | ▲ +57.96% | $0.1000 (−28.57%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers